1. Recent Advances in Herbal Medicines for Digestive System Malignancies
    Jiyao Sheng et al, 2018, Frontiers in Pharmacology CrossRef
  2. Cantharidic acid induces apoptosis of human leukemic HL‐60 cells via c‐Jun N‐terminal kinase‐regulated caspase‐8/‐9/‐3 activation pathway
    Shih‐Chung Wang et al, 2018, Environmental Toxicology CrossRef
  3. Dietary Phytochemicals as a Potential Source for Targeting Cancer Stem Cells
    Prasath Manogaran et al, 2021, Cancer Investigation CrossRef
  4. Norcantharidin Inhibits cell growth by suppressing the expression and phosphorylation of both EGFR and c-Met in human colon cancer cells
    Peiju Qiu et al, 2017, BMC Cancer CrossRef
  5. Cantharidin induces apoptosis of human triple negative breast cancer cells through mir-607-mediated downregulation of EGFR
    Tianfeng Yang et al, 2023, Journal of Translational Medicine CrossRef
  6. Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1
    Galina Semenova et al, 2017, Biochimie CrossRef
  7. Glycyrrhizic Acid-Based Liposome for Tumor-Targeted Delivery of Cantharidin
    Yuxiang Wang et al, 2024, ACS Applied Nano Materials CrossRef
  8. Gynura divaricata attenuates tumor growth and tumor relapse after cisplatin therapy in HCC xenograft model through suppression of cancer stem cell growth and Wnt/β-catenin signalling
    Chia-Hung Yen et al, 2018, Journal of Ethnopharmacology CrossRef
  9. Significance of a PTEN Mutational Status-Associated Gene Signature in the Progression and Prognosis of Endometrial Carcinoma
    Ying Wu et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
  10. Chinese Herbal Medicine for Primary Liver Cancer Therapy: Perspectives and Challenges
    Kexin Li et al, 2022, Frontiers in Pharmacology CrossRef
  11. Anticancer Attributes of Cantharidin: Involved Molecular Mechanisms and Pathways
    Faiza Naz et al, 2020, Molecules CrossRef
  12. 18-GA-Suc Modified Liposome Loading Cantharidin for Augmenting Hepatic Specificity: Preparation, Characterization, Antitumor Effects, and Liver-Targeting Efficiency
    Kun Zhu et al, 2020, Journal of Pharmaceutical Sciences CrossRef
  13. Cantharidic acid induces apoptosis through the p38 MAPK signaling pathway in human hepatocellular carcinoma
    I‐Che Feng et al, 2018, Environmental Toxicology CrossRef
  14. Multifunctional self-assembled micelles of galactosamine-hyaluronic acid-vitamin E succinate for targeting delivery of norcantharidin to hepatic carcinoma
    Shulong Jiang et al, 2018, Carbohydrate Polymers CrossRef
  15. Enhanced anticancer efficacy of cantharidin by mPEG-PLGA micellar encapsulation: An effective strategy for application of a poisonous traditional Chinese medicine
    Hailu Yao et al, 2020, Colloids and Surfaces B: Biointerfaces CrossRef
  16. Targeting the Proline–Glutamine–Asparagine–Arginine Metabolic Axis in Amino Acid Starvation Cancer Therapy
    Macus Kuo et al, 2021, Pharmaceuticals CrossRef
  17. Blister Beetle Dermatitis Outbreaks in Mali
    Guillaume Velut et al, 2023, Military Medicine CrossRef
  18. Hepatotoxic mechanism of cantharidin: insights and strategies for therapeutic intervention
    Dian Jin et al, 2023, Frontiers in Pharmacology CrossRef
  19. A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification
    Shenghao Li et al, 2023, Infectious Agents and Cancer CrossRef
  20. Methyl-Cantharidimide Inhibits Growth of Human Hepatocellular Carcinoma Cells by Inducing Cell Cycle Arrest and Promoting Apoptosis
    Xiangzhong Huang et al, 2019, Frontiers in Oncology CrossRef